Dipyridamole FDA Link Generic

A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)

Also Known As:

Persantine; Miosen; Antistenocardin; Apo-Dipyridamole; Cerebrovase; Cléridium; Curantil; Curantyl; Dipyramidole; Kurantil; Novo-Dipiradol; Persantin; Apo Dipyridamole; Novo Dipiradol; Ethanol, 2,2',2'',2'''- ((4,8- di- 1- piperidinylpyrimido(5,4- d)pyrimidine- 2,6- diyl)dinitrilo)tetrakis-

Pharmalogical Action Categories:

Phosphodiesterase Inhibitors
Platelet Aggregation Inhibitors
Vasodilator Agents

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Dipyridamole: 3288

Almudena Gil-Villarino Selected Research

Almudena Gil-Villarino Research Topics

Disease

Drug/Important Bio-Agent (IBA)